Berberine vs PQQ (Pyrroloquinoline Quinone)

Mechanism

Berberine activates AMP-activated protein kinase (AMPK), the master metabolic sensor, mimicking many effects of caloric restriction and exercise. It inhibits mitochondrial Complex I, increasing the AMP:ATP ratio which triggers AMPK. Downstream effects include enhanced GLUT4 translocation (glucose uptake), inhibition of HMG-CoA reductase (cholesterol synthesis), upregulation of LDL receptor expression, and suppression of PCSK9. It also modulates gut microbiome composition, increasing short-chain fatty acid-producing bacteria.

Standard Dosing

500mg 2-3x daily (1000-1500mg total)

Timing

With meals or immediately before meals (reduces postprandial glucose spike). Must be taken with food.

Cycle Duration

Cycle 8-12 weeks on, 4 weeks off (or continuous under practitioner supervision)

Side Effects

• GI cramping/diarrhea (dose-dependent)
• Constipation in some
• Abdominal distension
• Potential for hypoglycemia

Contraindications

• Pregnancy (uterotonic — may induce contractions)
• Lactation
• Concurrent use of multiple CYP3A4 metabolized drugs
• Severe liver disease
• Children under 12

Best Stacking Partners

Mechanism

PQQ activates PGC-1alpha via CREB phosphorylation, directly stimulating mitochondrial biogenesis — the formation of new mitochondria. It acts as a redox cycling agent capable of thousands of catalytic oxidation-reduction cycles (compared to ~4 for vitamin C), providing exceptional antioxidant capacity. PQQ also modulates NMDA receptor signaling and promotes nerve growth factor (NGF) synthesis, supporting neuronal health and cognitive function.

Standard Dosing

10-20mg daily

Timing

With breakfast. Can combine in same meal with CoQ10.

Cycle Duration

ongoing

Side Effects

• Rare: headache
• Mild GI discomfort at higher doses
• Insomnia if taken late

Contraindications

• Pregnancy/lactation (insufficient safety data)

Best Stacking Partners